ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Current filters:
Current filters:
Current filters:
Add filters:

Results 1-10 of 19 (Search time: 0.141 seconds).

SCIESCOPUS
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor

Kim, Y.[Kim, Y.]; Kim, C.H.[Kim, C.H.]; Lee, H.Y.[Lee, H.Y.]; Lee, S.[Lee, S.]; Kim, H.S.[Kim, H.S.]; Lee, S.[Lee, S.]; Cha, H.[Cha, H.]; Hong, S.[Hong, S.]; Kim, K.[Kim, K.]; Seo, S.W.[Seo, S.W.], et al.

ArticleIssue Date2019CitationJournal of Thoracic Oncology, v.14, no.9, pp.1608 - 1618PublisherElsevier Inc
SCIESCOPUSKCI
A randomized, Open-Label, phase II study comparing pemetrexed plus cisplatin followed by maintenance pemetrexed versus pemetrexed alone in patients with epidermal growth factor receptor (EGFR)-Mutant non-small cell lung cancer after failure of First-Line EGFR tyrosine kinase inhibitor: KCSG-Lu12-13open access

Yoo, K.H.[Yoo, K.H.]; Lee, S.J.[Lee, S.J.]; Cho, J.[Cho, J.]; Lee, K.H.[Lee, K.H.]; Park, K.[Park, K.]; Kim, K.H.[Kim, K.H.]; Cho, E.K.[Cho, E.K.]; Choi, Y.H.[Choi, Y.H.]; Kim, H.R.[Kim, H.R.]; Kim, H.-G.[Kim, H.-G.], et al.

ArticleIssue Date2019CitationCancer Research and Treatment, v.51, no.2, pp.718 - 726PublisherKorean Cancer Association
SCIESCOPUS
Osimertinib plus Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTONopen access

Hartmaier, RJ[Hartmaier, Ryan J.]; Markovets, AA[Markovets, Aleksandra A.]; Ahn, MJ[Ahn, Myung Ju]; Sequist, LV[Sequist, Lecia, V]; Han, JY[Han, Ji-Youn]; Cho, BC[Cho, Byoung Chul]; Yu, HA[Yu, Helena A.]; Kim, SW[Kim, Sang-We]; Yang, JCH[Yang, James Chih-Hsin]; Lee, JS[Lee, Jong-Seok], et al.

ArticleIssue Date2023CitationCANCER DISCOVERY, v.13, no.1, pp.98 - 113PublisherAMER ASSOC CANCER RESEARCH
SCIESCOPUS
Predictive Value of18 F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer

Yoo, J.[Yoo, J.]; Lee, J.[Lee, J.]; Cheon, M.[Cheon, M.]; Woo, S.-K.[Woo, S.-K.]; Ahn, M.-J.[Ahn, M.-J.]; Pyo, H.R.[Pyo, H.R.]; Choi, Y.S.[Choi, Y.S.]; Han, J.H.[Han, J.H.]; Choi, J.Y.[Choi, J.Y.]

ArticleIssue Date2022CitationCancers, v.14, no.8PublisherMDPI
SCIESCOPUS
Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC

Barlesi, F[Barlesi, Fabrice]; Garon, EB[Garon, Edward B.]; Kim, DW[Kim, Dong-Wan]; Felip, E[Felip, Enriqueta]; Han, JY[Han, Ji-Youn]; Kim, JH[Kim, Joo-Hang]; Ahn, MJ[Ahn, Myung-Ju]; Fidler, MJ[Fidler, Mary Jo]; Gubens, MA[Gubens, Matthew A.]; de Castro, G[de Castro, Gilberto, Jr.], et al.

ArticleIssue Date2019CitationJOURNAL OF THORACIC ONCOLOGY, v.14, no.5, pp.793 - 801PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

Kim, H.[Kim, H.]; Jung, H.A.[Jung, H.A.]; Lee, S.-H.[Lee, S.-H.]; Ahn, J.S.[Ahn, J.S.]; Ahn, M.-J.[Ahn, M.-J.]; Park, K.[Park, K.]; Sun, J.-M.[Sun, J.-M.]

ArticleIssue Date2021CitationTranslational Lung Cancer Research, v.10, no.2, pp.878 - 888PublisherAME Publishing Company
SCIESCOPUS
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Jung, HA[Jung, Hyun Ae]; Noh, JM[Noh, Jae Myoung]; Sun, JM[Sun, Jong-Mu]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok]; Ahn, MJ[Ahn, Myung-Ju]; Pyo, H[Pyo, Hongryull]; Ahn, YC[Ahn, Yong Chan]; Park, K[Park, Keunchil]

ArticleIssue Date2020CitationLUNG CANCER, v.146, pp.23 - 29PublisherELSEVIER IRELAND LTD
SCIESCOPUS
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Mitsudomi, T[Mitsudomi, Tetsuya]; Tan, D[Tan, Daniel]; Yang, JCH[Yang, James Chih-Hsin]; Ahn, MJ[Ahn, Myung-Ju]; Batra, U[Batra, Ullas]; Cho, BC[Cho, Byoung-Chul]; Cornelio, G[Cornelio, Gerardo]; Lim, T[Lim, Tony]; Mok, T[Mok, Tony]; Prabhash, K[Prabhash, Kumar], et al.

ArticleIssue Date2023CitationJOURNAL OF THORACIC ONCOLOGY, v.18, no.4, pp.436 - 446PublisherELSEVIER SCIENCE INC
SCIESCOPUSKCI
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapyopen access

Park, SE[Park, Song Ee]; Noh, JM[Noh, Jae Myoung]; Kim, YJ[Kim, You Jin]; Lee, HS[Lee, Han Sang]; Cho, JH[Cho, Jang Ho]; Lim, SW[Lim, Sung Won]; Ahn, YC[Ahn, Yong Chan]; Pyo, H[Pyo, Hongryull]; Choi, YL[Choi, Yoon-La]; Han, J[Han, Joungho], et al.

ArticleIssue Date2019CitationCANCER RESEARCH AND TREATMENT, v.51, no.2, pp.493 - 501PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Sequist, LV[Sequist, Lecia, V]; Han, JY[Han, Ji-Youn]; Ahn, MJ[Ahn, Myung-Ju]; Cho, BC[Cho, Byoung Chul]; Yu, H[Yu, Helena]; Kim, SW[Kim, Sang-We]; Yang, JCH[Yang, James Chih-Hsin]; Lee, JS[Lee, Jong Seok]; Su, WC[Su, Wu-Chou]; Kowalski, D[Kowalski, Dariusz], et al.

ArticleIssue Date2020CitationLANCET ONCOLOGY, v.21, no.3, pp.373 - 386PublisherELSEVIER SCIENCE INC
1 2

Discover

Date Issued

Type

Journal Index

STATISTICS
Total View :5,479,942
Today View :2,393

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어